Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 51, 2016 - Issue 6
Submit an article Journal homepage
193
Views
4
CrossRef citations to date
0
Altmetric
Letter to the editor

Unilateral and irreversible optic neuropathy associated to infliximab treatment: 3-year follow-up

Jose Javier Garcia-MedinaDepartment of Ophthalmology, General University Hospital Reina Sofia, Murcia, Spain; Department of Ophthalmology, General University Hospital Reina Sofia, Murcia, Spain; Ophthalmic Research Unit “Santiago Grisolia”, Valencia, SpainCorrespondence[email protected]
,
Ana Pastor-GrauDepartment of Ophthalmology, General University Hospital Reina Sofia, Murcia, Spain
,
Monica del-Rio-VellosilloDepartment of Anaesthesia, University Hospital Virgen De La Arrixaca, Murcia, Spain
,
Vicente Zanon-MorenoOphthalmic Research Unit “Santiago Grisolia”, Valencia, Spain
&
Maria Dolores Pinazo-DuranOphthalmic Research Unit “Santiago Grisolia”, Valencia, Spain;Department of Ophthalmology, School of Medicine, University of Valencia, Valencia, Spain
Pages 765-766 | Published online: 05 Jan 2016

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

David R. Jordan, John S. Y. Park & Danah Al-Breiki. (2022) Acute orbital inflammation with loss of vision: a paradoxical adverse event associated with infliximab therapy for Crohn’s disease. Orbit 41:6, pages 791-796.
Read now

Articles from other publishers (3)

Su Hwan Park, Min Seung Kang, Sang Yoon Kim, Ji-Eun Lee & Su Jin Kim. (2021) Infliximab-related Optic Neuritis in a Patient with Crohn's Disease: a Case Report and Literature Review. Journal of the Korean Ophthalmological Society 62:8, pages 1160-1166.
Crossref
Viktoria Papp, Annika R Langkilde, Morten Blinkenberg, Karen Schreiber, Poul Erik Hyldgaard Jensen & Finn Sellebjerg. (2018) Clinical utility of anti-MOG antibody testing in a Danish cohort. Multiple Sclerosis and Related Disorders 26, pages 61-67.
Crossref
. (2016) Infliximab. Reactions Weekly 1598:1, pages 129-129.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.